IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q2 2022 Holdings

Filed 2022-08-15 | 54 holdings | $312.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$26.3M317,5008.4%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$56.9M500,82718.2%
Corcept Therapeutics Inc(CORT)COM218352102$60.1M2,526,49019.3%
Boston Scientific Corp(BSX)COM101137107$130.8M3,508,78841.9%
PreviousPage 2 of 2